Literature DB >> 11862359

Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder.

Don R Cherek1, Scott D Lane, Cynthia J Pietras, Joel L Steinberg.   

Abstract

RATIONALE: The role of serotonin in human aggression and impulsivity was evaluated by administering paroxetine or placebo for 3 weeks and comparing the effects on laboratory measures of aggression and impulsivity among male subjects with a history of conduct disorder.
METHODS: Twelve male subjects with a history of criminal behavior participated in experimental sessions, which measured aggressive and impulsive responses. Six subjects were assigned to placebo treatment and six subjects to placebo and paroxetine treatment. Aggression was measured using the point subtraction aggression paradigm (PSAP), which provides subjects with an aggressive and monetary reinforced response options. Impulsive responses were measured using a paradigm that gives subjects choices between small rewards after short delays versus larger rewards after longer delays.
RESULTS: Chronic administration of paroxetine (20 mg/day) for 21 days produced significant decreases in impulsive responses. Decreases in aggressive responses were evident only at the end of paroxetine treatment. Decreases in impulsive and aggressive responses could not be attributed to a non-specific sedative action because monetary reinforced responses were not decreased as has been observed following CNS sedation.
CONCLUSIONS: Inhibition of serotonin reuptake by paroxetine is the possible mechanism for reductions in aggressive and impulsive responses. These results support other data linking serotonin function and aggression and impulsivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11862359     DOI: 10.1007/s002130100915

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

Review 1.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Authors:  R Andrew Chambers; Jane R Taylor; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

2.  Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

Authors:  Atsuo Nakagawa; Michael F Grunebaum; Steven P Ellis; Maria A Oquendo; Haruo Kashima; Robert D Gibbons; J John Mann
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

3.  Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior.

Authors:  Joshua L Gowin; Charles E Green; Joseph L Alcorn; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  J Psychopharmacol       Date:  2011-07-05       Impact factor: 4.153

Review 4.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

Review 5.  Pharmacological aspects of the treatment of conduct disorder in children and adolescents.

Authors:  Oleg V Tcheremissine; Lori M Lieving
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus.

Authors:  Aki Takahashi; Arielle N Schilit; Jisoo Kim; Joseph F Debold; Tsuyoshi Koide; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

7.  Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI.

Authors:  Katya Rubia; Francis Lee; Anthony J Cleare; Nigel Tunstall; Cynthia H Y Fu; Michael Brammer; Phillip McGuire
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

8.  The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.

Authors:  K Peremans; K Audenaert; Y Hoybergs; A Otte; I Goethals; I Gielen; P Blankaert; M Vervaet; C van Heeringen; R Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06       Impact factor: 9.236

Review 9.  Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Authors:  Jonathan Ipser; Dan J Stein
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

10.  Citalopram intervention for hostility: results of a randomized clinical trial.

Authors:  Thomas W Kamarck; Roger F Haskett; Matthew Muldoon; Janine D Flory; Barbara Anderson; Robert Bies; Bruce Pollock; Stephen B Manuck
Journal:  J Consult Clin Psychol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.